Your browser is no longer supported. Please, upgrade your browser.
Settings
NEO NeoGenomics, Inc. daily Stock Chart
NEO [NASD]
NeoGenomics, Inc.
Index- P/E307.19 EPS (ttm)0.06 Insider Own3.40% Shs Outstand93.80M Perf Week-9.94%
Market Cap1.84B Forward P/E58.86 EPS next Y0.33 Insider Trans-83.46% Shs Float86.90M Perf Month1.13%
Income6.10M PEG15.36 EPS next Q0.04 Inst Own77.40% Short Float8.20% Perf Quarter26.84%
Sales276.70M P/S6.66 EPS this Y137.90% Inst Trans0.43% Short Ratio8.40 Perf Half Y40.23%
Book/sh3.99 P/B4.93 EPS next Y42.74% ROA1.50% Target Price22.13 Perf Year110.04%
Cash/sh0.10 P/C188.17 EPS next 5Y20.00% ROE2.50% 52W Range9.08 - 22.17 Perf YTD55.91%
Dividend- P/FCF60.46 EPS past 5Y11.50% ROI2.00% 52W High-11.32% Beta0.93
Dividend %- Quick Ratio1.60 Sales past 5Y33.00% Gross Margin46.00% 52W Low116.61% ATR0.78
Employees1500 Current Ratio1.70 Sales Q/Q24.60% Oper. Margin3.60% RSI (14)43.48 Volatility4.97% 4.03%
OptionableYes Debt/Eq0.35 EPS Q/Q125.60% Profit Margin2.20% Rel Volume0.80 Prev Close19.57
ShortableYes LT Debt/Eq0.31 EarningsApr 30 BMO Payout0.00% Avg Volume847.89K Price19.66
Recom1.40 SMA20-4.03% SMA501.70% SMA20025.11% Volume677,530 Change0.46%
Mar-29-19Reiterated Needham Buy $19 → $22
Jan-03-19Initiated Needham Buy $14
Oct-24-18Upgrade First Analysis Sec Outperform → Strong Buy $18
Aug-21-18Initiated Leerink Partners Outperform $18
May-02-18Downgrade First Analysis Sec Overweight → Equal-Weight $11
Sep-11-17Downgrade BTIG Research Buy → Neutral
Aug-24-17Initiated Gabelli & Co Buy $9
Dec-15-16Initiated Cantor Fitzgerald Overweight $11
Oct-04-16Initiated First Analysis Sec Overweight $11
Jul-27-16Reiterated The Benchmark Company Buy $10 → $12
Apr-28-16Reiterated The Benchmark Company Buy $8 → $9
Mar-11-16Initiated The Benchmark Company Buy $8
Oct-26-15Resumed ROTH Capital Buy $7.50 → $10
Jul-13-15Reiterated ROTH Capital Buy $7 → $7.50
May-14-14Initiated Dawson James Buy $6
Apr-25-13Downgrade Ladenburg Thalmann Buy → Neutral
Feb-14-13Reiterated Ladenburg Thalmann Buy $3.50 → $3.75
Apr-03-19 04:35PM  NeoGenomics Schedules its First Quarter Earnings Release for April 30, 2019 ACCESSWIRE
Apr-02-19 05:20PM  NeoGenomics to Present at 18th Annual Needham & Company Health Care Conference ACCESSWIRE
Mar-28-19 07:20AM  Report: Developing Opportunities within Carter's, Ingredion, NeoGenomics, American Financial Group, Inogen, and Forrester Research Future Expectations, Projections Moving into 2019 GlobeNewswire
Mar-11-19 12:59PM  Here's Why Genetic Testing Stocks Rose as Much as 42.9% in February Motley Fool
07:00AM  NeoGenomics Launches Immuno-Oncology Companion Diagnostic Test for Triple Negative Breast Cancer in Conjunction with FDA Approval for TECENTRIQ(R) ACCESSWIRE
Mar-07-19 04:50PM  NeoGenomics To Present At 39th Annual Cowen and Company Health Care Conference ACCESSWIRE
Feb-23-19 07:09PM  Back Above $4k: Bitcoins Price Jumps to a Two-Month High Coindesk
Feb-20-19 09:43AM  Edited Transcript of NEO earnings conference call or presentation 19-Feb-19 1:30pm GMT Thomson Reuters StreetEvents
Feb-19-19 02:22PM  Neogenomics Inc (NEO) Q4 2018 Earnings Conference Call Transcript Motley Fool
07:32AM  NeoGenomics: 4Q Earnings Snapshot Associated Press
07:00AM  NeoGenomics Reports Record Revenue of $76 Million with 17% Organic Revenue Growth in the Fourth Quarter GlobeNewswire
06:30AM  NeoGenomics, Inc. to Host Earnings Call ACCESSWIRE
Feb-13-19 08:55AM  Zacks.com featured highlights include: Ready Capital, Gladstone, NeoGenomics, Digi and Paramount Zacks
Feb-12-19 03:00PM  Is NeoGenomics, Inc. (NASDAQ:NEO) Excessively Paying Its CEO? Simply Wall St.
10:30AM  NeoGenomics (NEO) Reports Next Week: What to Know Ahead of the Release Zacks
08:19AM  5 Breakout Stocks for Stellar Returns Zacks
Feb-08-19 10:33PM  Here's Why Genetic Testing Stocks Rose as Much as 31.8% in January Motley Fool
Jan-29-19 01:10PM  NeoGenomics Is Poised For Further Gains - Go Long on a Shallow Dip TheStreet.com
09:30AM  Is NeoGenomics (NEO) Outperforming Other Medical Stocks This Year? Zacks
Jan-28-19 07:00AM  NeoGenomics Schedules its Fourth Quarter and Fiscal Year 2018 Earnings Release for February 19, 2019 GlobeNewswire
Jan-22-19 07:11PM  3 Top Growth Stocks to Buy Right Now Motley Fool
Jan-18-19 07:40AM  Report: Developing Opportunities within Macerich, Illinois Tool Works, NeoGenomics, Bunge, Dolby Laboratories, and Cracker Barrel Old Country Store Future Expectations, Projections Moving into 2019 GlobeNewswire
Jan-09-19 12:41PM  Here's Why NeoGenomics Rocketed Higher Today Motley Fool +13.84%
Jan-08-19 05:58PM  NeoGenomics Set to Join S&P SmallCap 600 PR Newswire
Dec-25-18 09:30AM  Is NeoGenomics (NEO) Stock Outpacing Its Medical Peers This Year? Zacks
Dec-21-18 05:45PM  NeoGenomics (NEO) Stock Moves -1.04%: What You Should Know Zacks
Dec-19-18 12:45AM  NeoGenomics, Inc. (NEO): Hedge Funds Are Snapping Up Insider Monkey
Dec-17-18 10:10AM  GE Sells Last of Its NeoGenomics Stock for $130 Million Barrons.com -5.21%
Dec-14-18 06:57AM  The Zacks Analyst Blog Highlights: Anthem, Ensign, NeoGenomics, Merit Medical Systems and Medpace Zacks
Dec-13-18 10:32AM  5 Healthcare Bets to Stay in Investors Good Books Next Year Zacks
07:00AM  NeoGenomics Appoints Dr. Lawrence M. Weiss as Chief Scientific Officer GlobeNewswire
Dec-12-18 07:35AM  NeoGenomics Announces Pricing on Secondary Offering of Common Stock by Selling Stockholder GlobeNewswire
Dec-11-18 04:10PM  NeoGenomics Announces Secondary Offering of Common Stock by Selling Stockholder GlobeNewswire
Dec-10-18 09:10AM  NeoGenomics Completes Acquisition of Genoptix, Inc. GlobeNewswire
Dec-06-18 09:30AM  Is NeoGenomics (NEO) Outperforming Other Medical Stocks This Year? Zacks -6.57%
Dec-03-18 09:33AM  QIAGEN (QGEN) Partners NeoGenomics to Widen CDx Tests Reach Zacks
Nov-30-18 05:01PM  QIAGEN and NeoGenomics collaborate to offer cancer patients Day-One access to innovative companion diagnostics for newly approved drugs GlobeNewswire
04:04PM  QIAGEN and NeoGenomics collaborate to offer cancer patients Day-One access to innovative companion diagnostics for newly approved drugs Business Wire
Nov-27-18 10:44AM  Eyenovia Initiates Phase III Study for Mydriasis Candidate Zacks
Nov-12-18 03:00PM  What Kind Of Investor Owns Most Of NeoGenomics Inc (NASDAQ:NEO)? Simply Wall St.
07:35AM  Research Report Identifies Ironwood Pharmaceuticals, The AES, Accuray, Ball, Park Hotels & Resorts, and NeoGenomics with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Nov-05-18 09:09PM  Edited Transcript of NEO earnings conference call or presentation 30-Oct-18 12:30pm GMT Thomson Reuters StreetEvents
Oct-30-18 03:33PM  Dow Jones Leads Fragile Rebound; Will This Sector Head A Recovery? Investor's Business Daily +10.41%
08:35AM  NeoGenomics (NEO) Q3 Earnings and Revenues Top Estimates Zacks
07:31AM  NeoGenomics: 3Q Earnings Snapshot Associated Press
07:00AM  NeoGenomics Reports 17% Revenue Growth to Record $69 Million GlobeNewswire
Oct-23-18 01:01PM  [$$] NeoGenomics to Buy Genoptix Inc. for $138.7 Million The Wall Street Journal
07:00AM  NeoGenomics Signs Definitive Agreement to Acquire Genoptix GlobeNewswire
Oct-18-18 09:10AM  Consolidated Research: 2018 Summary Expectations for MaxLinear, NeoGenomics, Intrepid Potash, Glu Mobile, Ingles Markets, and Ball Fundamental Analysis, Key Performance Indications GlobeNewswire
Oct-01-18 07:00AM  NeoGenomics Schedules its Third Quarter Earnings Release for October 30, 2018 GlobeNewswire
Sep-24-18 07:00AM  NeoGenomics Announces Participation in NCI-MATCH Clinical Trial GlobeNewswire
Sep-12-18 08:14AM  NeoGenomics Awarded Clinical Reference Laboratory Testing Services Agreement with Premier GlobeNewswire
Aug-27-18 08:00AM  Research Report Identifies Ball, Aethlon Medical, NeoGenomics, Del Taco Restaurants, Arconic, and Agilysys with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Aug-09-18 08:40PM  NeoGenomics Announces Pricing on Public Offering of Common Stock GlobeNewswire
Aug-06-18 04:19PM  NeoGenomics Announces Proposed Public Offering of Common Stock GlobeNewswire
Jul-30-18 09:30AM  EBS vs. NEO: Which Stock Should Value Investors Buy Now? Zacks
Jul-27-18 07:45AM  Breakfast Technical Briefing on TrovaGene and Three Other Additional Medical Research Stocks ACCESSWIRE
Jul-24-18 07:03PM  Edited Transcript of NEO earnings conference call or presentation 24-Jul-18 12:30pm GMT Thomson Reuters StreetEvents
07:18AM  NeoGenomics: 2Q Earnings Snapshot Associated Press
07:00AM  NeoGenomics Reports Record Revenue of $67.7 Million with 14% Increase in Clinical Volume Growth and 95% Increase in Pharma Services Backlog GlobeNewswire
06:30AM  NeoGenomics, Inc. to Host Earnings Call ACCESSWIRE
Jul-23-18 04:18PM  Earnings Preview For NeoGenomics Benzinga
Jul-11-18 09:30AM  EBS vs. NEO: Which Stock Is the Better Value Option? Zacks
Jul-02-18 04:05PM  NeoGenomics Schedules its Second Quarter Earnings Release for July 24, 2018 GlobeNewswire +5.03%
Jun-29-18 07:30AM  [$$] GE Is Doing Well---in Its Stock Investments Barrons.com
Jun-26-18 02:25PM  Is NeoGenomics Incs (NASDAQ:NEO) Balance Sheet Strong Enough To Weather A Storm? Simply Wall St.
Jun-25-18 04:05PM  NeoGenomics Redeems 100% of Series A Redeemable Preferred Stock GlobeNewswire
Jun-21-18 08:00AM  Report: Developing Opportunities within ABIOMED, Avid Technology, Unit, Omeros, Strayer Education, and NeoGenomics Future Expectations, Projections Moving into 2018 GlobeNewswire
Jun-01-18 08:00AM  PPD and NeoGenomics Forming Global Strategic Alliance for Pathology and Molecular Testing Solutions GlobeNewswire +8.10%
May-25-18 04:05PM  NeoGenomics to Participate In Two Upcoming Investor Conferences GlobeNewswire
May-02-18 05:35PM  Edited Transcript of NEO earnings conference call or presentation 1-May-18 12:30pm GMT Thomson Reuters StreetEvents
May-01-18 09:45AM  NeoGenomics: 1Q Earnings Snapshot Associated Press
07:45AM  Detailed Research: Economic Perspectives on NeoGenomics, Illinois Tool Works, Carriage Services, Gorman-Rupp, Fiesta Restaurant Group, and American Financial Group What Drives Growth in Today's Competitive Landscape GlobeNewswire
07:00AM  NeoGenomics Reports Revenue of $63.4 Million, Net Income of $0.6 Million and Adjusted EBITDA of $9.2 Million in the First Quarter of 2018 Marketwired
06:45AM  NeoGenomics, Inc. to Host Earnings Call ACCESSWIRE
Apr-02-18 05:00PM  NeoGenomics Schedules its First Quarter Earnings Release for May 1, 2018 Marketwired
Mar-20-18 07:00AM  NeoGenomics Announces Executive Appointments Marketwired
Mar-19-18 08:25AM  Research Report Identifies Chatham Lodging Trust (REIT), Independent Bank Group, NeoGenomics, Black Knight, Aethlon Medical, and PRA Group with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Mar-07-18 07:13AM  SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating NeoGenomics, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors PR Newswire
Feb-21-18 08:31PM  Edited Transcript of NEO earnings conference call or presentation 21-Feb-18 3:00pm GMT Thomson Reuters StreetEvents +9.78%
07:55AM  NeoGenomics beats Street 4Q forecasts Associated Press
07:20AM  NeoGenomics, Inc. to Host Earnings Call ACCESSWIRE
07:00AM  NeoGenomics Reports Revenue of $67.8 Million on 18.7% Clinical Volume Growth and $10.5 Million of Adjusted EBITDA in the Fourth Quarter of 2017 Marketwired
Jan-30-18 07:00AM  NeoGenomics Schedules its Fourth Quarter and Fiscal Year 2017 Earnings Release for February 21, 2018 Marketwired
Jan-09-18 07:30AM  Detailed Research: Economic Perspectives on Fluidigm, Stemline Therapeutics, NeoGenomics, CVR Energy, W.R. Berkley, and Mack-Cali Realty What Drives Growth in Today's Competitive Landscape GlobeNewswire
Jan-01-18 07:42AM  NeoGenomics, Inc. breached its 50 day moving average in a Bearish Manner : NEO-US : January 1, 2018 Capital Cube
Dec-19-17 01:42PM  ETFs with exposure to NeoGenomics, Inc. : December 19, 2017 Capital Cube
Dec-18-17 11:13AM  NeoGenomics, Inc. :NEO-US: Earnings Analysis: Q3, 2017 By the Numbers : December 18, 2017 Capital Cube
Dec-15-17 02:47PM  NeoGenomics, Inc. Value Analysis (NASDAQ:NEO) : December 15, 2017 Capital Cube
Dec-14-17 08:05AM  NeoGenomics, Inc. breached its 50 day moving average in a Bearish Manner : NEO-US : December 14, 2017 Capital Cube
Dec-06-17 07:00AM  NeoGenomics Announces Six Clinical Data Presentations to be Made at the American Society of Hematology Meeting Marketwired
Dec-05-17 07:00AM  NeoGenomics Joins Thermo Fisher Scientific's Companion Diagnostic Center of Excellence Program with the Launch of Oncomine Dx Target Test Marketwired
Nov-15-17 08:05AM  See what the IHS Markit Score report has to say about Neogenomics Inc. Markit
Nov-14-17 08:05AM  Zacks.com highlights: Apache, PTC, NeoGenomics, Titan International and AMC Entertainment Holdings Zacks
Nov-09-17 07:00AM  NeoGenomics Europe S.A. Opens its Doors in Rolle, Switzerland Laboratory Hosting Business Leaders, Dignitaries and Local Government Officials Marketwired
Oct-25-17 04:26PM  Edited Transcript of NEO earnings conference call or presentation 25-Oct-17 2:00pm GMT Thomson Reuters StreetEvents
07:21AM  NeoGenomics reports 3Q loss Associated Press
07:05AM  NeoGenomics, Inc. to Host Earnings Call ACCESSWIRE
07:00AM  NeoGenomics Reports Revenue of $63.1 Million on 17% Volume Growth and 11% Reduction in Average Cost per Test in the Third Quarter of 2017 Marketwired
Oct-24-17 04:10PM  Investor Network Invites You to the NeoGenomics Third Quarter 2017 Earnings Conference Call and Webcast Live on Wednesday, October 25, 2017 ACCESSWIRE -5.97%
NeoGenomics, Inc., together with its subsidiaries, operates a network of cancer-focused genetic testing laboratories in the United States; and laboratories in Switzerland and Singapore. It operates in two segments, Clinical Services and Pharma Services. The company's laboratories provide genetic and molecular testing services to hospitals, pathologists, oncologists, urologists, other clinicians and researchers, pharmaceutical firms, academic centers, and other clinical laboratories. It offers cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; immunohistochemistry and digital imaging testing services to localize proteins in cells of a tissue section, as well as to allow clients to see and utilize scanned slides, and perform quantitative analysis for various stains; and molecular testing services, which focus on the analysis of DNA and RNA, and the structure and function of genes at the molecular level. The company also provides pathology consultation services for clients in which its pathologists review surgical samples on a consultative basis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization, as well as acts as a reference laboratory supplying anatomic pathology testing services. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BALLIET JENNIFERVP and Chief Culture OfficerMar 04Option Exercise8.0314,000112,42036,862Mar 04 05:25 PM
BALLIET JENNIFERVP and Chief Culture OfficerMar 04Sale19.0914,000267,26022,862Mar 04 05:25 PM
SHOVLIN ROBERT J.President, Clinical ServicesFeb 28Option Exercise7.1513,986100,000137,377Feb 28 05:05 PM
BALLIET JENNIFERVP and Chief Culture OfficerFeb 28Option Exercise7.6930,000230,70050,000Mar 04 05:25 PM
BALLIET JENNIFERVP and Chief Culture OfficerFeb 28Sale19.5730,000587,10020,000Mar 04 05:25 PM
CARDOZA GEORGEPresident, Pharma ServicesFeb 27Option Exercise3.4530,000103,500244,089Feb 28 07:42 PM
JONES STEVEN CExecutive Vice PresidentFeb 27Sale18.89285,2525,387,378150,000Feb 28 08:25 PM
SHOVLIN ROBERT J.President, Clinical ServicesFeb 27Sale19.2344,135848,716123,391Feb 28 05:05 PM
HIPP RAYMOND RDirectorFeb 26Option Exercise6.4918,889122,646306,469Feb 28 04:57 PM
Bonello WilliamChief Strategy OfficerFeb 26Option Exercise7.8660,203473,21160,203Feb 28 04:59 PM
SHOVLIN ROBERT J.President, Clinical ServicesFeb 26Option Exercise7.28186,0141,354,667309,405Feb 28 05:05 PM
SHOVLIN ROBERT J.President, Clinical ServicesFeb 26Sale18.88141,8792,678,676167,526Feb 28 05:05 PM
Bonello WilliamChief Strategy OfficerFeb 26Sale18.9060,2031,137,8370Feb 28 04:59 PM
HIPP RAYMOND RDirectorFeb 26Sale18.9018,889357,002287,580Feb 28 04:57 PM
JONES STEVEN CExecutive Vice PresidentFeb 26Sale19.2414,621281,36547,657Feb 28 08:25 PM
Johnson Kevin CDirectorDec 21Buy11.6026,000301,600103,866Dec 26 07:08 PM
GENERAL ELECTRIC COFormer 10% OwnerDec 14Sale12.0010,835,145130,021,7400Dec 14 04:05 PM
TETRAULT LYNN A.DirectorNov 19Sale16.0013,000207,94038,234Nov 21 01:33 PM
TETRAULT LYNN A.DirectorNov 15Option Exercise7.4918,888141,43756,234Nov 16 05:18 PM
TETRAULT LYNN A.DirectorNov 14Sale16.165,00080,80051,234Nov 16 05:18 PM
JONES STEVEN CExecutive Vice PresidentNov 14Sale16.505,55391,625184,271Nov 14 07:30 PM
JONES STEVEN CExecutive Vice PresidentNov 13Sale16.6935,574593,610186,000Nov 14 07:30 PM
BALLIET JENNIFERVP and Chief Culture OfficerNov 12Sale16.7328,505476,88920,000Nov 13 08:46 PM
SHOVLIN ROBERT J.President, Clinical ServicesNov 12Sale16.7636,493611,623123,391Nov 13 10:27 AM
JONES STEVEN CExecutive Vice PresidentNov 12Sale16.66100,0001,666,0002,200,000Nov 14 07:30 PM
BALLIET JENNIFERVP and Chief Culture OfficerNov 09Option Exercise2.4568,333167,30088,333Nov 13 08:46 PM
SHOVLIN ROBERT J.President, Clinical ServicesNov 09Option Exercise4.79300,0001,437,000339,884Nov 13 10:27 AM
BALLIET JENNIFERVP and Chief Culture OfficerNov 09Sale17.0039,828677,07648,505Nov 13 08:46 PM
Johnson Kevin CDirectorNov 09Sale17.0366,0071,124,18077,866Nov 13 10:48 AM
SHOVLIN ROBERT J.President, Clinical ServicesNov 09Sale17.05180,0003,069,000159,884Nov 13 10:27 AM
GENERAL ELECTRIC CO10% OwnerNov 09Sale16.754,164,85569,761,32110,835,145Nov 13 05:05 PM
BRODIE STEVEN G.VP - Pharma OperationsOct 22Option Exercise3.4513,33446,00245,953Oct 24 06:36 PM
JONES STEVEN CExecutive Vice PresidentAug 01Sale14.00119,9481,679,2722,300,000Aug 01 07:56 PM
JONES STEVEN CExecutive Vice PresidentJul 31Sale14.0038,952545,3282,419,948Aug 01 07:56 PM
JONES STEVEN CExecutive Vice PresidentJul 30Sale14.0144,600624,81148,657Aug 01 07:56 PM
SHOVLIN ROBERT J.President, Clinical ServicesJun 29Sale13.1212,941169,78639,884Jun 29 05:21 PM
JONES STEVEN CExecutive Vice PresidentJun 22Sale14.0489,6881,259,2202,500,000Jun 26 05:29 PM
JONES STEVEN CExecutive Vice PresidentJun 19Sale13.32158,3122,108,0672,589,688Jun 19 06:54 PM
JONES STEVEN CExecutive Vice PresidentJun 15Sale13.252,00026,5002,748,000Jun 19 06:54 PM
JONES STEVEN CExecutive Vice PresidentJun 01Sale12.12230,5332,794,0602,750,000Jun 05 05:42 PM
JONES STEVEN CExecutive Vice PresidentMay 31Sale11.6817,548204,9612,980,533May 31 05:54 PM
JONES STEVEN CExecutive Vice PresidentMay 30Sale11.7237,619440,8952,998,081May 31 05:54 PM
BALLIET JENNIFERVP and Chief Culture OfficerMay 29Option Exercise4.7865,000310,70078,322May 31 05:50 PM
JONES STEVEN CExecutive Vice PresidentMay 29Sale11.67114,3001,333,8813,035,700May 31 05:54 PM
BALLIET JENNIFERVP and Chief Culture OfficerMay 29Sale11.6665,000758,10013,322May 31 05:50 PM
VAN OORT DOUGLAS MChairman and CEOMay 25Option Exercise0.0065,68001,898,665May 29 07:00 PM
CARDOZA GEORGEPresident, Pharma ServicesMay 25Option Exercise0.008,3330197,422May 29 06:57 PM
BALLIET JENNIFERVP and Chief Culture OfficerMay 25Option Exercise0.006,66606,666May 29 06:51 PM
SHOVLIN ROBERT J.President, Clinical ServicesMay 25Option Exercise0.0016,666023,216May 29 06:36 PM
BALLIET JENNIFERVP and Chief Culture OfficerMay 15Option Exercise4.7813,00062,14013,000May 17 03:35 PM
BALLIET JENNIFERVP and Chief Culture OfficerMay 15Sale11.2413,000146,0550May 17 03:35 PM
ROSS STEVEN ACIOMay 10Option Exercise6.2781,999514,51886,499May 10 05:53 PM
ROSS STEVEN ACIOMay 10Sale10.7881,999883,9494,500May 10 05:53 PM